Commercial launch planning should begin early in Phase II, says the company
QPharma (Morristown, NJ), which offers a variety of consulting services, mostly in the commercial operations realm, is expanding its reach with an advisory service for clinical products. Peter Shaw, chief medical officer, says that the service is especially attuned to small- to medium-sized biopharma companies that are trying to reach the commercialization phase in drug development.
Services include recruiting, training, and managing sales teams; engaging clinical key opinion leaders; ensuring compliance with federal and state regulations; establishing programs for the management and distribution of samples; and designing and launching appropriate marketing campaigns. Shaw adds that Qpharma has relationships with a number of specialized consulting organizations that can be brought into the process; among these is Qforma (Morris Plains, NJ; which, despite its name, is separate from QPharma). Qforma has a software package called Ilaunch that is essentially a project-management tool for drug commercialization.
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.